冠状动脉疾病相关变异对血管平滑肌细胞的影响
该研究对超过1499份血管平滑肌细胞(VSMC)进行基因分型、RNA测序和细胞行为实验,发现约60%的已知CAD相关变异在VSMC中具有显著的表达或剪接数量性状位点效应,共定位分析识别出84个候选因果基因,其中38个为可成药靶点,多基因评分模型可解释高达5.94%的VSMC行为参数变异。
要点
- 约60%的CAD相关变异在VSMC中显示显著的eQTL或sQTL效应。
- 共定位分析识别出84个候选因果基因,38个可成药,13个有药物-基因相互作用证据。
- 139个CAD相关变异与VSMC增殖、迁移或凋亡提示相关,多基因评分解释高达5.94%的行为变异。
核心结论
- 大部分CAD相关变异可通过调控VSMC基因表达和影响VSMC行为发挥作用,所识别的部分候选因果基因可成药,具有治疗靶点潜力。
研究设计与样本
- 对超过1499份血管平滑肌细胞进行基因分型、RNA测序和细胞行为实验,并开展eQTL、sQTL、共定位、可成药性及多基因评分分析。
主要发现
- 约60%的已知CAD相关变异在VSMC中显示统计学显著的eQTL或sQTL效应。
- 共定位分析识别出84个候选因果基因,其中38个可成药,13个有药物-基因相互作用证据。
- 139个CAD相关变异与VSMC增殖、迁移或凋亡提示相关。
- 多基因评分模型可解释高达5.94%的VSMC行为参数变异。
临床怎么用
- 可关注所识别的可成药候选因果基因作为潜在治疗靶点,但需进一步验证。
局限性
- 原文摘要未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genome-wide association studies have identified many genetic loci that are robustly associated with coronary artery disease (CAD). However, the underlying biological mechanisms are still unknown for most of these loci, hindering the progress to medical translation. Evidence suggests that the genetic influence on CAD susceptibility may act partly through vascular smooth muscle cells (VSMCs). METHODS: We undertook genotyping, RNA sequencing, and cell behavior assays on a large bank of VSMCs (n>1499). Expression quantitative trait locus and splicing quantitative trait locus analyses were performed to identify genes with an expression that was influenced by CAD-associated variants. To identify candidate causal genes for CAD, we ascertained colocalizations of VSMC expression quantitative trait locus signals with CAD association signals by performing causal variants identification in associated regions analysis and the summary data-based mendelian randomization test. Druggability analysis was then performed on the candidate causal genes. CAD risk variants were tested for associations with VSMC proliferation, migration, and apoptosis. Collective effects of multiple CAD-associated variants on VSMC behavior were estimated by polygenic scores. RESULTS: Approximately 60% of the known CAD-associated variants showed statistically significant expression quantitative trait locus or splicing quantitative trait locus effects in VSMCs. Colocalization analyses identified 84 genes with expression quantitative trait locus signals that significantly colocalized with CAD association signals, identifying them as candidate causal genes. Druggability analysis indicated that 38 of the candidate causal genes were druggable, and 13 had evidence of drug-gene interactions. Of the CAD-associated variants tested, 139 showed suggestive associations with VSMC proliferation, migration, or apoptosis. A polygenic score model explained up to 5.94% of variation in several VSMC behavior parameters, consistent with polygenic influences on VSMC behavior. CONCLUSIONS: This comprehensive analysis shows that a large percentage of CAD loci can modulate gene expression in VSMCs and influence VSMC behavior. Several candidate causal genes identified are likely to be druggable and thus represent potential therapeutic targets.
引用
- Solomon CU, McVey DG, Andreadi C, et al. Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle Cells. Circulation. 2022. PMID: 35735005. doi:10.1161/CIRCULATIONAHA.121.058389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。